H2020Индивидуална стипендия2019–2022

EpIg Men · The Role of Antibodies (Ig) and the Respiratory Epithelium in the Prevention of Invasive Meningococcal Infections in Different Age Groups

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период: 2019-07-01 → 2022-05-02
Финансиране от ЕС: 187 572 €
Участници: 1
Схема: MSCA-IF-EF-RI

Линиите свързват координатора с партньорите.

Накратко на български

Различните генетични линии на менингококите се изследват за това как проникват през лигавицата на дихателните пътища и колко са устойчиви на антитела. Това помага да се разбере как се предотвратяват тежките инвазивни инфекции при различни възрастови групи.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

The Role of Antibodies (Ig) and the Respiratory Epithelium in the Prevention of Invasive Meningococcal Infections in Different Age Groups

Meningococci causing invasive meningococcal disease (IMD) have distinct genetic signatures, referred to as clonal complexes or sequence types, compared to non-invasive meningococci found in carriage studies. A well-known clonal complex associated with IMD is cc11. In this project we aim to elucidate how distinct genetic lineages differ in their ability to infect the cells that form the wall of the upper respiratory tract, the epithelial cells. Upon infection and crossing the epithelial barrier the complement system is the main line of defense against meningococci. Therefore we also aimed to investigate whether genetic lineages vary in their resistant to complement-mediated killing. Antibodies enhance the ability of complement to kill meningococci. Therefore antibody levels and the ability of vaccine-induced antibodies to promote complement-mediated killing is studied.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Highly invasive meningococcal infections with serogroup W of clonal type cc11 are rapidly increasing and have a high (16-25%) mortality rate. The aim of this project is to investigate why recent isolates are invasive and how different antibodies can protect. Special focus will be on protection of epithelial cells of the wall of the respiratory tract as prevention of infection may be key to protect the public against infection with MenW cc11.Recent clinical isolates of different clinical invasiveness will be subjected to pangenetic analyses to identify virulence factors. The ability of these isolates to infect epithelial cells will be evaluated to compare virulence factors with functional invasiveness. I then will analyse meningococcal-specific antibody levels in serum and saliva in different age groups with increased carriage and/or risk of meningococcal invasive disease. The antibodies will be evaluated for their ability to protect against infection in two different functional assays: prevention of infection of respiratory epithelial cells and the gold standard serum bactericidal assay that predicts the ability to clear invaded meningococci. Finally, epithelial responses to meningococci and modulation of these responses will be investigated. These studies will analyse cytokine and chemokine production, and the production of antibodies by B cells in epithelial-B cell co-cultures.Together, these data will a) help to identify meningococcal virulence factors and the invasiveness of MenW cc11 relative to other isolates, b) identify levels and functional ability of antibodies to protect against infection in groups at increased risk, c) help in defining a novel correlate of protection and d) reveal meningococcal-epithelial interactions. The results will provide insight for vaccine design, vaccination policy and surveillance strategies.

Оригинален текст от CORDIS (на английски).

Участници

RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (RIVM) · BILTHOVENКоординаторНидерландия